| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.47B | 116.06B | 93.91B | 76.09B | 57.64B | 42.87B |
| Gross Profit | 77.88B | 62.45B | 51.27B | 42.42B | 30.57B | 20.23B |
| EBITDA | 51.55B | 45.10B | 36.63B | 30.98B | 22.36B | 14.53B |
| Net Income | 35.60B | 30.76B | 25.38B | 21.91B | 15.54B | 10.01B |
Balance Sheet | ||||||
| Total Assets | 133.47B | 124.67B | 99.88B | 75.27B | 58.14B | 46.04B |
| Cash, Cash Equivalents and Short-Term Investments | 68.80B | 63.55B | 45.78B | 36.61B | 26.06B | 16.30B |
| Total Debt | 5.74B | 8.08B | 9.65B | 4.14B | 5.21B | 6.98B |
| Total Liabilities | 28.47B | 30.26B | 25.76B | 17.92B | 16.43B | 16.02B |
| Stockholders Equity | 105.00B | 94.40B | 74.13B | 57.34B | 41.70B | 30.02B |
Cash Flow | ||||||
| Free Cash Flow | 34.37B | 31.78B | 20.72B | 21.25B | 15.94B | 11.93B |
| Operating Cash Flow | 34.77B | 32.65B | 24.35B | 21.64B | 16.02B | 12.13B |
| Investing Cash Flow | -4.24B | -3.53B | -3.75B | -2.26B | -147.00M | -364.00M |
| Financing Cash Flow | -19.33B | -14.34B | -11.42B | -8.83B | -6.11B | -3.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥24.40B | 16.33 | ― | 3.50% | 15.91% | 36.39% | |
72 Outperform | ¥111.99B | 16.22 | ― | 3.44% | 10.28% | -20.11% | |
71 Outperform | ¥700.99B | 28.67 | ― | 1.30% | 25.07% | 26.47% | |
71 Outperform | ¥22.22B | 8.70 | ― | 2.18% | 17.87% | 5.31% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥59.72B | 34.13 | ― | 2.96% | 10.63% | 7.42% | |
63 Neutral | ¥17.12B | 95.88 | ― | ― | 16.77% | 39.98% |